Streetwise Company Fact Sheet2026/9/8 19:08:47
(SVA:TSX - SEOVF:OTCQB - PSH0:XETRA)
Analyst coverage
| Leede Financial Inc. — Dr. Douglas Loe |
| H.C. Wainwright & Co. — Dr. Joseph Pantginis |
| Research Capital Corporation — Dr. Andre Uddin |
Newsletter coverage
| — |
Company News
| View Latest News |
Streetwise Reports Articles
| 09/08/2026 - View Article |
| 06/19/2026 - View Article |
| 06/18/2026 - View Article |
| 03/05/2026 - View Article |
| 01/13/2026 - View Article |
Streetwise - Sernova Biotherapeutics Inc. Ownership Overview*
Sernova Biotherapeutics Inc. (SVA:TSX; SEOVF:OTCQB; PSH0:XETRA)
Restructures
| Date | Old Symbol | Old Shares | New Symbol | New Shares |
|---|---|---|---|---|
| 09/20/06 | PHS:TSX | 1 | SVA:TSX | 1 |
| 03/02/00 | MEC:TSX | 1 | PHS:TSX | 1 |
*Share Structure as of 9/8/2026
Company News
9/8/2026 – Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
6/17/2026 – Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
© 2026 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
